MedTrace Logo

Supported Employment and Skills Training in Conjunction With Pharmacotherapy in Schizophrenia Patients

NCT00183625 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 107

Last updated 2026-02-09

Study results available
· View outcomes & findings →

Summary

This study will compare employment support with behavioral skills training to employment support alone in schizophrenia patients taking either risperidone or olanzapine to determine which is more effective in helping the patients maintain a job.

Conditions

Interventions

BEHAVIORAL

Individual Placement and Support (Supported Employment)

BEHAVIORAL

Social Skills Training

DRUG

Olanzapine

DRUG

Risperidone

Sponsors & Collaborators

Principal Investigators

  • Stephen R. Marder, MD · University of California, Los Angeles

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-06-30
Primary Completion
2005-06-30
Completion
2006-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00183625 on ClinicalTrials.gov